Wegovy and Skin: Separating Myth from What the Evidence Actually Shows

The biggest misconception: that Wegovy directly damages your skin

A phrase that comes up often in online forums is that semaglutide 'ruins your skin' as a side effect of the drug itself. It's worth letting that one go gently, because it conflates several different things.

The NHS medicines page for semaglutide lists the recognised side effects of Wegovy: gastrointestinal symptoms dominate (nausea, diarrhoea, constipation) along with injection-site reactions and fatigue. There is no listed effect of generalised skin deterioration. What people are often describing is either injection-site irritation, dryness linked to eating and drinking less, or the natural consequence of significant fat loss changing the skin's appearance. Each of those has its own explanation and its own set of practical responses. Treating them as one thing called 'Wegovy skin damage' leads to unnecessary alarm.

That said, skin changes are real and worth understanding properly. If you'd like a detailed look at how dryness specifically relates to treatment, the piece on Wegovy and dry skin covers the mechanisms in more depth.

Injection-site reactions: what's normal and what to watch for

The most common skin-related complaint on Wegovy is local: redness, mild swelling, itching or a small bruise at the injection point. These reactions appear in the clinical trial data and are well-documented. They typically settle within a day or two.

Rotating injection sites (abdomen, thigh and outer upper arm are the three licensed areas) is the single most effective way to reduce the frequency and severity of these reactions. Using a fresh needle each time and allowing the pen to reach room temperature before injecting also helps. If you notice persistent pain, significant swelling, warmth spreading from the site, or any sign of infection, contact a clinician promptly rather than waiting until your next review. The guide to skin pain with Wegovy goes into this in more detail.

Some people describe a harder or raised area under the skin after repeated injections at the same spot, this is lipohypertrophy, a well-known phenomenon from insulin injection practice. It reinforces why site rotation matters. If you're unsure whether what you're experiencing is normal, our support team is available seven days a week.

Loose skin and changes in skin texture during weight loss

Significant weight loss (the kind that clinical trials of semaglutide produced) inevitably affects skin that was previously stretched over a larger volume of fat. This is not a Wegovy-specific problem; it applies to any sustained weight loss, whether from diet, surgery or medication. The STEP 1 trial, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose. Losing 15% of your body weight in a little over a year is a meaningful physical change, and skin adapts at its own pace.

Elasticity declines with age, prior stretch, sun damage and genetics, factors that exist independently of any medicine. Slower, gradual loss gives skin more time to retract; faster loss may leave more visible laxity. Adequate protein intake, hydration and resistance training alongside treatment are commonly recommended to support skin integrity, though these are lifestyle adjustments rather than prescribed medical instructions. For personalised guidance, your prescriber or a dietitian is the right person to speak to.

Concerns about the neck and jaw area in particular come up often. If loose skin around the neck is something you're thinking about, there's a specific page on Wegovy and neck skin that addresses the evidence.

Dryness, rashes and other skin signals worth knowing about

Some people on GLP-1 treatment notice their skin feels drier than usual. The likeliest explanation is reduced appetite leading to lower overall fluid and food intake; dehydration, even mild, affects skin turgor. It is not a listed pharmacological action of semaglutide on skin cells. Staying well hydrated and maintaining a balanced diet matters more during treatment than it might have done before.

A small number of people report a generalised itching or rash. If you are experiencing soreness at or around the injection site rather than a generalised rash, the page on Wegovy sore skin explains what tends to cause it and when to seek advice. If a rash is widespread, rapidly spreading, or accompanied by swelling of the lips, tongue or face and difficulty breathing, that is a potential allergic reaction requiring immediate medical attention, call 999. More minor itching away from the injection site is worth reporting to your prescriber at your next review rather than self-managing indefinitely.

For a broader look at how semaglutide interacts with the body, the overview of semaglutide and skin covers the evidence across both its licensed uses. You can also find the full summary of Wegovy's side-effect profile on the Wegovy treatment page.

If any skin symptom is bothering you and you're unsure whether it's related to your treatment, suspected side effects can be reported directly through the MHRA's Yellow Card scheme, something we'd always encourage.

Skin changes are one part of a larger picture. If you're weighing up whether Wegovy is right for you, take a look at the weight-loss treatment overview, or check your eligibility with a free consultation with one of our prescribers.